Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
Operating Income Growth TrendStable
Percentile Rank93
3Y CAGR+26.8%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+26.8%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthStable
PeriodValue
202522.76%
202421.91%
202346.21%
202211.17%
2021-142.76%
2020-11.68%
2019-18.09%
2018-12.49%
2017-9.72%
2016-122.37%